$ONTX News Article - Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma https://marketwirenews.com/news-releases/onco...92860.html
Traws Pharma Inc. (TRAW) Stock Research Links
My Twitter: WhyteStocks